NASDAQ · Drug Manufacturers - Specialty & Generic
Aurora Cannabis Inc. (ACB) Stock
$4.49
+1.35%
NASDAQ: ACB
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
ACB Stock Down 28% in Three Months: Time to Buy the Dip or Cash Out?
Zacks · Jul 15, 2026
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive · Jul 13, 2026
Aurora Named to TIME Canada's Best Companies 2026 List
CNW Group · Jul 9, 2026
VFF Stock Loses 27% in Three Months: Time to Invest or Exit?
Zacks · Jul 8, 2026
Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders
CNW Group · Jul 8, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held1.27%
Institutions Held9.70%
Institutions Float Held9.83%
Peer Comparison
About Aurora Cannabis Inc.
Aurora Cannabis Inc. is led by CEO Miguel Martin, employs 1,073 people, headquartered in CA, publicly traded since 2014.
Aurora Cannabis Inc. (ACB) stock trades at $4.49 with a market capitalization of $278.12M. The stock is valued at a price-to-earnings (P/E) ratio of -2.89, price-to-book of 0.65, price-to-sales of 1.19. Over the past 52 weeks the stock has ranged between $2.56 and $6.67, and currently trades 32.7% below its 52-week high.
On profitability, Aurora Cannabis Inc. generates a return on equity (ROE) of -21.00%, return on capital employed of -15.72%, an operating margin of 1.46%, a net profit margin of -38.15%.